TAIWAN Trends and Developments Contributed by: Eddie Hsiung, Tsung-Yuan Shen and Nita Ye, Lee and Li, Attorneys-at-Law
Lee and Li, Attorneys-at-Law 8F, No 555 Sec. 4 Zhongxiao E. Rd Taipei 110055 Taiwan
Tel: +886 2 2763 8000 Fax: +886 2 2766 5566 Email: attorneys@leeandli.com Web: www.leeandli.com/TW
Exploring Taiwan’s AI Applications in Healthcare Taiwan is globally recognised as a leader in the semiconductor industry, renowned not only for its advanced manufacturing capabilities but also for its comprehensive integrated supply chain, from design and fabrication to packaging and testing. Recently, the rapid emergence of artificial intelligence technologies, particularly those using generative AI, have triggered an unprecedented surge in demand for advanced semiconductor chips. The cutting-edge applications made possible by AI require increasingly sophisticat - ed and high-performance chips. At present, Taiwan’s fully developed and sophisticated local supply chain gives its semiconductor industry a distinct competi - tive advantage over those of other regions. Similarly, the high standards of medical care in Tai - wan have earned it significant worldwide recognition in recent years. The global quality-of-life database Numbeo has ranked Taiwan number one in the world in its Health Care Index for the past seven years. The Health Care Index evaluates multiple factors, includ - ing the technical skills and competencies of medical personnel, the efficiency with which medical examina - tions and reports are completed, the quality of medical equipment and software, and the accuracy of medical reports that collectively reflect the overall quality of healthcare services. Moreover, Taiwan’s performance during the COVID-19 pandemic reinforced Taiwan’s standing as a worldwide leader in medical standards and public health management.
Taiwan’s competitiveness in both the semiconductor and medical sectors has positioned the island as an ideal location for developing AI applications within the healthcare industry. Taiwan’s National Health Insurance system The medical system in Taiwan is structured by a com - prehensive insurance framework known as National Health Insurance (NHI), which is a compulsory social insurance programme designed to provide universal health coverage to Taiwanese citizens. Under the National Health Insurance Act, NHI is exclu - sively managed by a single governmental agency, the National Health Insurance Administration (NHIA). This centralised management structure is a key factor in the system’s overall efficiency and adaptability. As of the most recent data, approximately 99.9% of the Tai - wanese population is enrolled in NHI. Benefiting from the NHI system, Taiwanese citizens enjoy affordable access to high-quality medical treatment. However, demographic trends are likely to bring new challenges to the NHI system in the near future. Like many countries around the world, Taiwan is experi - encing a rapidly ageing population. Societal shifts, including delayed marriage and low fertility rates, have contributed to a significant demographic transforma - tion within Taiwan, with the island being classified as an “aged society” (in which 14% of the population is aged 65 or over) starting in 2018, and projected to be classified as a “super-aged society” (in which
116 CHAMBERS.COM
Powered by FlippingBook